Cabot Corporation (CBT): what the price assumes

boothcheck covers Cabot Corporation (CBT) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/CBT

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 9.4% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

The price is supported by earnings-power and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.6%); the inversion above states its own rate.

Per-Model Detail (n=13)

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Bullet Takeaways

• Cabot earned a 16.3% operating margin on $3.58 billion of trailing revenue while most of its commodity-chemical cohort was losing money at the operating line, with CELANESE (CE) at -7.8% and HUNTSMAN (HUN) at -3.3%.
• The fragile piece is Reinforcement Materials, 63% of revenue, sold under contracts the 10-K describes as arrangements "with certain customers, the typical duration of which is one year", and this year's reset took that segment's profit down 29% in the March quarter.
• Next information event is the plant rationalization in South America and Europe, which management sized at about 22 million dollars of annualized fixed-cost savings once fully implemented.

Bull Case

Watch where the cash goes. During fiscal 2025 the company repurchased "approximately 1.7 million shares of common stock on the open market for $159 million", and in the March 2026 quarter it spent another 49 million dollars on repurchases alongside 24 million dollars of dividends. In May it lifted the quarterly payout 5%, taking the annualized dividend from 1.80 to 1.89 a share. The share count has come down about 2.2% a year over the four years to March 2026. None of that is dramatic. It is the profile of a management team that has decided its own equity is a reasonable place to put money, and has kept deciding that through a soft patch in its largest end market.

What funds it is a business that stayed profitable while its neighbours did not. Trailing operating income of $587 million on $3.58 billion of revenue works out to a 16.3% operating margin. Read across the cohort and that number stops looking ordinary: CELANESE (CE) is currently running a -7.8% operating margin on $9.5 billion of revenue, TRONOX (TROX) is at -8.0%, HUNTSMAN (HUN) at -3.3%, and OLIN (OLN) at -1.7%. Four large chemical franchises, three of them bigger by revenue, none of them turning sales into operating profit at the moment. Cabot is keeping about a sixth of every sales dollar.

Some of that gap is structural rather than clever. The principal input to reinforcing carbons is a leftover from someone else's process, described in the 10-K as "by-product residual heavy oils derived from petroleum refining operations, the distillation of coal tars", and the customer agreements carry feedstock indices that move the selling price when that input moves. A business that buys a refinery by-product and sells a specified particle is not really trading a spread. It is selling a formulation, and formulations are harder to substitute than tonnage.

The second segment is where the growth actually sits. Performance Chemicals, 34% of revenue, grew segment profit 18% year over year in the March quarter on battery materials and specialty carbons volumes. The 10-K states the driver without embellishment: "Demand for our conductive additives for use in batteries is largely driven by the trend in electrification of vehicles and the increase in energy storage systems." That is a product line attached to grid storage and vehicle electrification, sitting inside a company the market prices as a tire-input supplier. Against the specialty peers in that cohort, Cabot's whole-company margin runs above SENSIENT (SXT) at 13.3%, AVIENT (AVNT) at 9.1% and IFF at 7.4%, and below NEWMARKET (NEU) at 19.6%.

The bear is right that the tire contracts reset annually and reset lower this year. What the same quarter also showed is global Reinforcement Materials volume up 3%, with Asia Pacific up 5%. Customers are taking more product. The argument is about price per ton, not about whether anyone still wants the ton.

Bear Case

Strip the price back to what it is actually paying for and it is not growth. What the price embeds is an operating-income decline of about 2.7% a year over a five-year stage, which is shallow enough that almost everything rests on whether today's profit level is the right description of the business. That makes one assumption load-bearing above all others: the Reinforcement Materials margin. And that is precisely the piece that gets renegotiated every twelve months.

The 10-K is direct about the mechanism, describing supply arrangements "with certain customers, the typical duration of which is one year". The March quarter showed what one bad reset costs. Segment profit in Reinforcement Materials fell by 38 million dollars against the prior year, a 29% decline, which management attributed to lower pricing and product mix in the calendar 2026 tire customer agreements and to increased competitive intensity in Asia Pacific. Volumes moved the other way in that same quarter, rising rather than falling. Shipping more and earning less is what a price reset looks like from the inside, and the next one lands on the same annual clock.

Where the competitive pressure comes from is also disclosed. The 10-K notes that among specialty carbons and battery materials competitors, "a number of these companies that operate regionally have increased the export of products outside their region of manufacture". The risk section then names the variables that decide the outcome, and none of them are within the company's control: "Our industry is highly competitive and demand for our products and our financial results may be negatively impacted by changes in industry capacity utilization, a material shift in the geographic area of tire production (in particular, shifts away from higher margin regions), and competition from other specialty chemical companies." Shifts away from higher-margin regions is the clause worth sitting with, because the volume growth this year came fastest in Asia Pacific, which is where the pricing pressure was named.

The feedstock pass-through that helps the bull case is a lag rather than a hedge, and the filing says so: "the indices we use in our supply arrangements may not precisely track our actual costs". Management flagged elevated energy costs and the Middle East conflict as live pressures on the back half of fiscal 2026. Price increases to offset input costs are the stated plan, and the March quarter is a working demonstration of how well price increases hold when a customer holds an annual contract.

If the margin reverts toward what the rest of the cohort is currently earning, the balance sheet math changes character quickly. Net debt of about 1.08 billion dollars sits at roughly 1.8 times operating profit today, and interest is covered 7.9 times over. Both of those are ratios with operating income underneath them, and CELANESE (CE), HUNTSMAN (HUN) and TRONOX (TROX) are all at negative operating margins right now, which is what that denominator disappearing looks like in this industry. Management is not waiting to find out. The plan announced in May is to close manufacturing operations in South America and Europe. Companies that expect demand to return generally do not rationalize the plants that would serve it.

Valuation

Start with what today's price assumes rather than what it is worth. The market is paying about ten times company-wide operating income, and what that price embeds is an operating-income decline of about 2.7% a year across a five-year stage. Against the company's own record and against the spread of multiples its sector carries, that reads as an ordinary assumption rather than a demanding one, and the multiple itself sits in the lower half of the peer range.

The methods used to triangulate do not agree, and the shape of the disagreement carries more information than any single output. The forward cash-flow family sits closest, with the price about 16% above where that family lands. The peer-multiple family is next, with the price about 19% above it, and the earnings-power family about 27% above. The book-value-plus-profitability reads land furthest below the price of any group. So nothing here is calling the stock cheap, and nothing is calling it heroic either. The price is above every static lens and nearest to the lenses that credit forward cash generation.

Inside the earnings-power group there is a split worth naming. Capitalize the five-year average of operating income, with one-time charges added back and no growth assumed at all, and the result lands above today's price. Capitalize last year's free cash flow the same way, at the same cost of equity, and it lands below. The two approaches share an idea and disagree about an input: whether Cabot is best described by the average of a cycle or by the most recent year of it. For a company whose largest segment reprices annually with tire makers, that is a genuine open question rather than a modeling quirk, and the report has no business resolving it into one number.

The segment split is where the answer will come from. The March-quarter filing puts Reinforcement Materials revenue from external customers at 544 million dollars and Performance Chemicals at 328 million dollars, with segment profit of 93 and 59 million dollars respectively. The larger business is the one shrinking in profit; the smaller one is the one growing. Management's own filed marker for the year is a company-defined adjusted earnings range of 6.00 to 6.50 a share for fiscal 2026, reaffirmed in May, and that figure excludes the certain items Cabot reports separately.

Cohort position sharpens the picture in an unusual direction. A 16.3% trailing operating margin is not what this peer set looks like at the moment, with CELANESE (CE) at -7.8%, TRONOX (TROX) at -8.0%, HUNTSMAN (HUN) at -3.3% and OLIN (OLN) at -1.7%. Buying the better current margin at a below-median multiple is the trade being offered. The catch, which the earnings-power split already exposed, is that a cyclical peak margin bought at a cheap multiple and a sustainable margin bought at a cheap multiple look identical from the outside.

The balance sheet is not what decides this. Net debt of about 1.08 billion dollars against trailing operating income of 587 million dollars comes to roughly 1.8 times operating profit, and interest is covered 7.9 times over. Cash stood at 252 million dollars at the end of March, and the company is not burning it. In May it replaced its former revolving facility with a larger unsecured one running to 2031, under a leverage test that permits net debt up to 3.75 to 1.00 against consolidated EBITDA. That is wide headroom against a ratio currently running near half of it. The financing is settled; the tire contract cycle is not.

Catalysts

The most recent print landed on May 5, 2026. Second-quarter fiscal 2026 net sales were 904 million dollars against 936 million a year earlier, with diluted earnings of $1.27 a share. The two segments moved in opposite directions: Reinforcement Materials profit of 93 million dollars was down 29% on lower pricing and product mix in the calendar 2026 tire agreements, while Performance Chemicals profit of 59 million dollars rose 18% on battery materials and specialty carbons volumes. Global Reinforcement Materials volumes rose 3%, led by Asia Pacific at 5%, with Europe, Middle East and Africa at 3% and the Americas at 1%. The same release carried a 5% increase in the quarterly dividend, lifting the annualized rate from 1.80 to 1.89 a share.

Two forward items came with it. Management reaffirmed a company-defined adjusted earnings range of 6.00 to 6.50 a share for fiscal 2026, while flagging the conflict in the Middle East, elevated energy costs and the possibility of softer demand late in the fiscal year; the stated plan is to hold margins with price increases that offset higher input costs. Separately, the company said it intends to rationalize capacity at facilities in South America and Europe, subject to local consultation processes, for annualized fixed-cost savings of about 22 million dollars once fully implemented. Watch whether those closures stay on the announced footing or widen; a rationalization that grows is a demand signal, not a cost story.

The financing side was settled a week later. On May 12, 2026 Cabot entered a 1.3 billion dollar unsecured revolving credit agreement maturing May 12, 2031, replacing its former one billion dollar facility, with an applicable margin between 0.68% and 1.20% depending on credit ratings. The facility carries a quarterly leverage test permitting net debt up to 3.75 to 1.00 against consolidated EBITDA, stepping up to 4.25 to 1.00 for four quarters following a material acquisition. That acquisition carve-out is the detail worth marking. A company that negotiates deal headroom into a five-year facility is keeping an option open, and the next quarterly report is the first place any use of it would surface.

Peer Cohorts (Per Segment, With Filing Citations)

Reinforcement Materials (reported)

• OLN (Olin Corporation)
• FY2025 10-K: …regulations and laws, including TSCA and REACH, or changes in their interpretation may reduce the demand for our products, impact our ability to use or manufacture certain products, or limit our ability to implement our strategies, any of which could have a material adverse effect on our business. A material change…
• FY2025 10-K: …treatment activities are higher. Our Epoxy segment also serves a number of applications which experience their highest level of activity during the spring and summer months, particularly civil engineering and protective coatings and other construction materials, including composites and flooring. RAW MATERIALS Basic…
• TROX (TRONOX HOLDINGS PLC)
• FY2025 10-K: …revoked or reduced in the future, or if they do not adequately combat China's unfair trade practices, our results of operations and financial position could be adversely impacted. We also benefit from the duties issued by the U.S. government pursuant to Section 301 of the Trade Act of 1974 on Chinese-origin TiO 2…
• FY2025 10-K: …distributed globally with more than seven members and a dedicated security operations center. Item 2. Properties SUMMARY DISCLOSURE Below are our primary offices and facilities at December 31, 2025. We believe our properties are in good operating condition, and are well maintained. Pursuant to separate financing…
• CE (CELANESE CORPORATION)
• FY2025 10-K: Asia and consist of 51 global production facilities and an additional 20 strategic affiliate production facilities. As of December 31, 2025, we employed 11,434 people worldwide. Business Segment Overview We operate principally through two business segments: Engineered Materials and the Acetyl Chain. See Business…
• FY2025 10-K: …additional downgrades; • volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene diamine, Polyamide 66 ("PA66"), polybutylene terephthalate,…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: ™ , and SunTek ™ window and protective films. 10 Tab le of Contents ADDITIVES & FUNCTIONAL PRODUCTS SEGMENT Overview In the AFP segment, the Company manufactures materials for products in the food, feed, and agriculture; transportation; water treatment and energy; personal care and wellness; building and construction;…
• FY2025 10-K: …polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma; and consumables end-markets. Key technology platforms for this segment include cellulosic biopolymers, copolyesters, and PVB and…
• HUN (Huntsman Corporation)
• FY2025 10-K: …of suppliers. We consume certain amines produced by our Performance Products segment and isocyanates produced by our Polyurethanes segment, which we use to formulate our Advanced Materials products. For additional information about our risks of raw material supply chain disruptions, see "Part I. Item 1A. Risk…
• FY2025 10-K: …is purchased pursuant to long-term contracts and delivered to our Pensacola, Florida site by barge and to our facility in Geismar, Louisiana via pipeline. For additional information about our risks of raw material supply chain disruptions, see "Part I. Item 1A. Risk Factors." Competition There are a small number of…
• FUL (FULLER H B CO)
• FY2025 10-K: …by supply and demand market mechanisms. Raw material costs, including costs for unique or specialty chemicals used in the manufacturing of our products, are primarily determined by the balance of supply against the aggregate demand from the adhesives industry and other industries that use the same raw material…
• FY2025 10-K: …and export controls, including the regulations of the U.S. Treasury Department's Office of Foreign Assets Control ("OFAC"). We do not conduct any business in the following countries that are subject to U.S. economic san ctions: Cuba, Iran, North Korea, Syria and the Crimea region of the Ukraine. Competition Our…

Performance Chemicals (reported)

• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: …and operational excellence. Examples include produced acetic anhydride used in the manufacturing of cellulosic biopolymers and acetyl stream product lines, propylene and ethylene used in the production of olefin derivative product lines such as oxo alcohols and plasticizers. The CI segment also provides superior…
• FY2025 10-K: …and assess performance of the Company. The CODM evaluates segment operating performance, and makes resource allocation and performance evaluation decisions, based on Adjusted EBIT, defined as the GAAP measure earnings before interest and taxes ("EBIT"), adjusted for non-core, unusual, or non-recurring items. These…
• SXT (Sensient Technologies Corp)
• FY2025 10-K: …positions as of December 31, 2025. As part of its commitment to quality as a competitive advantage, the Company's production facilities hold various certifications, such as those under the International Organization for Standardization (ISO) and those recognized by the Global Food Safety Initiative (GFSI), including…
• FY2025 10-K: …exceptions, the Company is no longer subject to federal, state, and local, or non-U.S. income tax examinations by tax authorities for years before 2021. 12. Segment and Geographic Information The accounting policies of the segments are the same as those described in the summary of significant accounting policies. The…
• NEU (NEWMARKET CORPORATION)
• FY2025 10-K: …is characterized by the need to provide customers with cost-effective, technologically-capable products that meet or exceed industry specifications. The need to continually increase technology performance and lower cost through formulation technology and cost improvement programs is vital for success in this…
• FY2025 10-K: …and OEMs worldwide. Afton continues to successfully implement techniques to drive efficiency in technology discovery and development, while aligning our internal testing to market changes, research, customer support, and predictive capabilities around the world in support of our goals of providing market-driven…
• AVNT (AVIENT CORPORATION)
• FY2025 10-K: …No customer accounted for more than 3% of our consolidated revenues in 2025. Research and Development One of our strategic drivers is to "Amplify Innovation," and we have substantial technology and development capabilities, powered by approximately 1,100 employees serving in technical capacities, approximately 120 of…
• FY2025 10-K: …cooling, anti-static, electrostatic discharge, and electromagnetic shielding performance for critical applications including integrated circuit chip packaging. Various additives can also be formulated with a base resin and further engineered into a composite to provide them with greater versatility and performance.…
• IFF (INTERNATIONAL FLAVORS & FRAGRANCES INC)
• FY2025 10-K: …for fresh dairy, cheese, bakery and brewing products. Such products contribute to extended shelf life, stability, taste, and texture, helping IFF's customers to improve their product offerings. The business's enzyme solutions also allow IFF's customers to provide low sugar, high fiber and lactose-free dairy products.…
• FY2025 10-K: …regulations, and although the impact of future changes cannot be predicted with certainty, compliance has not had, and is not expected to have, a material adverse effect on our capital expenditures, earnings, or competitive position. Our products and operations are regulated by governmental agencies in the local…
• FUL (FULLER H B CO)
• FY2025 10-K: …new high-performance solutions that enable customers to improve their products and processes to better achieve their sustainability programs. Regulatory Compliance The Company is subject to various federal, state, local and foreign laws and regulations relating to environmental protection and workers' safety,…
• FY2025 10-K: Research and Development Our investment in research and development creates new and innovative adhesive technology platforms, enhances product performance, ensures a competitive cost structure and leverages available raw materials. New product development is a key research and development outcome, providing…
• ALB (Albemarle Corporation)
• FY2025 10-K: …epoxies and other engineered resins. Competition Our Ketjen segment serves the global market including the Americas, Asia, Europe and the Middle East, each of which is highly competitive. Competition in these markets is driven by a variety of factors. Product performance, quality, price, contract terms, product and…
• FY2025 10-K: …Our raw material and energy costs can be volatile and may increase significantly. Increases are primarily driven by tightening of market conditions and major increases in the pricing of key constituent materials for our products such as crude oil, chlorine and metals (including molybdenum and rare earths, which are…
• CE (CELANESE CORPORATION)
• FY2025 10-K: …as well as the manner in which the information is used internally by the Company's chief operating decision maker ("CODM"), who is the Company's President and Chief Executive Officer. The Company's CODM regularly reviews the Operating profit of each reportable segment to assess financial results and allocate…
• FY2025 10-K: …and withstanding deformation. Nylon compounds are used in a range of applications including automotive, consumer, electrical, electronic and industrial. These value-added applications in diverse end uses support the business' global growth objectives. POM, PBT and LFRT are used in a broad range of…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.